MONOPOLISTIC BEHAVIOUR

China regulator fines two pharma firms for monopoly behaviour

The regulator fined Grand Pharmaceutical 136 million yuan ($19.68 million) and confiscated 149 million yuan of "illegal revenue" for entering into a monopolistic deal with Wuhan Healcare Pharmaceuticals.